Articles On Nanollose (ASX:NC6)

Stockhead’s In-Case-You-Missed-It highlights some of the strongest-performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentag...

The ASX closed out the day flat, thanks to a last-minute selling spree Qantas announces record profit but still won’t give us back the money we gave them during Covid Westar Resources won the Small Caps race, in spite of a 90-minute hobbli...

4DMedical  announced a significant breakthrough in imaging technology Bod Australia announced updates on its Aqua Phase Delivery technology Nanollose to strengthen balance sheet after receiving R&D tax rebate   4DMedical says its CT t...

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms...

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms....

Biomaterial tech company Nanollose is adding to its growing portfolio of intellectual property, filing a new provisional patent application with IP Australia, this time for its alternative seed germination and plant growing material Jelli G...

Stockhead’s In Case You Missed It highlights some of the strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage...

Stockhead’s In Case You Missed It highlights some of the strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage...

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms....

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today. It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms....

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms...

Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million   Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s...

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms...

Nanollose has completed its second pilot spin of its sustainable Nullarbor lyocell fibre, successfully increasing the microbial cellulose content. Australia-based biomaterial technology company Nanollose (ASX:NC6) has completed a milestone...

Benchmark set to finish close to flat as Energy stocks slump again Goldies are surging again, with that sector up 1.3% for the day Even the big banks are bracing for trouble with talk of a crisis getting louder by the day   After a modera...

Nanollose has extended its deal with fibre manufacturing conglomerate Grasim Industries as it works to get its forest-friendly Nullarbor fibres to market. Australia-based biomaterial technology company Nanollose (ASX:NC6) has announced it...

ASX hammered as bank-driven fear grips the market like a python round a possum XEC Emerging Companies falls more than 2.0% because they’re young and don’t know any better Safe haven goldies still managed to make bank. Sorry… poor choice of...

Nanollose has achieved another key milestone as it works to help the fashion world become more eco-friendly and develop fibres with minimal environmental impact. Australia-based biomaterial technology company Nanollose (ASX:NC6) has secured...

ASX weathers a US bank collapse storm to finish the day down just 0.5% XEC Emerging Companies index down 0.84% because it was out partying all weekend. The Goldies take the gongs, after the precious metal jumped more than 1.0%   Looking a...

The FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have grown exponentially in the marketplace We take a look at what it all means for the cannabis industry   The US FDA announced last week that:...

Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past...

Nanollose’s tree-friendly Nullarbor-20 fibre has been made into denim and jeans through its collaboration deal with a global leader in sustainable denim. Australia-based biomaterial technology company Nanollose (ASX:NC6) has announced that...

ASX 200 closes with -1.8% loss Small cap index down -1.2% Up way more than 100% is Norfolk Minerals, the real NFL   Everyone in this part of the world seems pretty upset by the US Federal Reserve Chairman Jerome Powell – more so than the...

High-quality fabrics using Nanollose’s Forest-Friendly, Nullarbor staple fibre has been produced as the company works to improve fashion sustainability. Australia-based biomaterial technology company Nanollose (ASX:NC6) has announced 200 y...

We take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks from 2021 have gained since listing We also look at the best and worst performing ASX stocks over the past month   There were 191 ASX IPOs in...

Blood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks are in the blood clot space Top performing ASX healthcare stocks in the past month Blood clots were top of biotech news this week after re...

The ASX 200 gains 0.2%   Small caps end slightly lower  The hunt for red (ETF) September   The ASX 200 has made a decent fist of Thursday, rebounding in its own way and ending the session 0.2% higher. The energy sector led gains again. Th...

It’s quarterlies season as the ASX market announcements page becomes increasingly flooded with lodgements. The last day for companies to submit reports is the last business day of the first month after the prior quarter. If they don’t, they...

MoneyTalks is Stockhead’s regular drill down into what stocks investors are looking at right now. We’ll tap our extensive list of experts to hear what’s hot, their top picks, and what they’re looking out for. Today we hear from Ali Ukani, S...

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

The ASX 200 and XEC small cap indices rise Attention turns to Tuesday’s date with RBA destiny Celsius Resources is hot   The ASX 200 and the Emerging Markets (XEC) indices are both trading higher on Monday up about 1.2%, ahead of tomorrow...

Nanollose will launch a Lee Mathews designed garment made from its eco-friendly Nullarbor lyocell fibre at a leading international forum for sustainability in fashion this month. Australia-based biomaterial technology company Nanollose (AS...

Nanollose has signed a key deal with a major global fashion retailer as its eco-friendly microbial cellulose-based technology continues to attract world interest. Australian-based biomaterial technology company Nanollose (ASX: NC6) has anno...

Nanollose (NC6) signs a memorandum of understanding (MoU) with Industria de Diseño Textil (INDITEX), one of the world’s largest fashion retailers Under the non-exclusive MoU, Nanollose will initially give free samples of the company’s flag...

Nanollose has signed another key collaboration agreement as interest continues to grow in its eco-friendly microbial cellulose-based technology. Australian-based biomaterial technology company Nanollose (ASX: NC6) has entered into a collabo...

Nanollose (NC6) pens a collaboration agreement with Paradise Textiles in an aim to create a more sustainable fashion industry Under the agreement, the parties will work together to develop and manufacture yarn and textiles which will inclu...

Nanollose has entered a collaboration with an innovative vegan leather and materials company as interest continues to gain momentum in its eco-friendly microbial cellulose-based technology. Australian-based biomaterial technology company Na...

Nanollose (NC6) is collaborating with material innovation company, von Holzhausen, to create vegan leather from plants and other recycled content As part of the one-year deal, Nanollose will provide samples of treated and processed microbi...

Nanollose completes its first pilot spin of eco-friendly Nullarbor-20 lyocell fibre, signs partnerships and is in strong financial position in milestone quarter. Australian-based biomaterial technology company Nanollose Ltd (ASX: NC6) has...

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

Biomaterials company Nanollose (NC6) signs an exclusive one-year collaboration agreement with a leading sustainable denim manufacture Under the agreement, the companies will develop denim materials which will include Nanollose’s Nullarbor...

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

On the Bid is a Stockhead video series featuring a roundtable of experts discussing a new investment topic each week. In this edition, host Oriel Morrison discusses how we can achieve a sustainable future in the world of fashion, the devel...

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

Biomaterials company Nanollose (NC6) successfully completed its first pilot scale spin of its Nullarbor-20 fibre The spin was completed by Nanollose’s strategic partner, with it demonstrating the capacity for its technology to be integrate...

Nanollose has completed its hugely-anticipated pilot spin of its eco-friendly, sustainable Nullarbor-20 lyocell fibre, and some of the world’s leading fashion houses are lining up to get first touch. Australian-based biomaterial technology...

Nanollose has got a powerful new ally to promote its revolutionary technology converting fermented waste into environmentally friendly fibres.   Australian-based biomaterial technology company Nanollose Ltd (ASX: NC6)’s tree-free rayon fibr...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...